We are live on ! Find out more
MIRA icon

MIRA Pharmaceuticals
MIRA

11 hedge funds and large institutions have $704K invested in MIRA Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

590% more capital invested

Capital invested by funds: $102K → $704K (+$602K)

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

83% more funds holding

Funds holding: 6 → 11 (+5)

3.68% more ownership

Funds ownership: 0.66% → 4.34% (+3.7%)

Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
1
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CSI
Cross Staff Investments
New York
+$416K
2
VF
Virtu Financial
New York
+$52.5K
3
SEM
Suncoast Equity Management
Florida
+$43.4K
4
HF
HRT Financial
New York
+$33.3K
5
PWM
Praetorian Wealth Management
California
+$29.9K

Top Sellers

Rank Fund Capital Flow
1
GS
GTS Securities
New York
-$39.7K
2
AWM
AE Wealth Management
Kansas
-$10.9K
3
SSB
Sandy Spring Bank
Maryland
-$10.9K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
CSI
1
Cross Staff Investments
New York
$422K +$416K +383,401 New
VF
2
Virtu Financial
New York
$69K +$52.5K +48,397 +330%
SEM
3
Suncoast Equity Management
Florida
$44K +$43.4K +40,000 New
HF
4
HRT Financial
New York
$33K +$33.3K +30,651 New
PWM
5
Praetorian Wealth Management
California
$30.3K +$29.9K +27,500 New
XT
6
XTX Topco
Cayman Islands
$28.1K +$27.7K +25,544 New
Northern Trust
7
Northern Trust
Illinois
$22.5K – – –
FAB
8
First American Bank
Illinois
$22K +$21.7K +20,000 New
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$17.1K +$16.9K +15,573 New
CSPIA
10
Cary Street Partners Investment Advisory
Virginia
$11K +$10.9K +10,000 New
UBS Group
11
UBS Group
Switzerland
$5.25K +$5.18K +4,771 New
GS
12
GTS Securities
New York
– -$39.7K -37,852 Closed
SSB
13
Sandy Spring Bank
Maryland
– -$10.9K -10,375 Closed
AWM
14
AE Wealth Management
Kansas
– -$10.9K -10,000 Closed
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
– -$4K -3,500 Closed

MIRA Hedge Fund Activity: Q1 2024 in Review

11 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in MIRA Pharmaceuticals (MIRA) for Q1 2024, worth a combined $704K — up 590% from $102K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new MIRA positions and 4 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Cross Staff Investments, opening a new position worth an estimated $416K. The largest seller was GTS Securities, exiting entirely with an estimated $39.7K sold.

  • 11 institutional investors held MIRA Pharmaceuticals (MIRA) as of Q1 2024, up from 6 in Q4 2023.
  • Funds reported $704K of MIRA Pharmaceuticals stock for Q1 2024, up 590% quarter-over-quarter.
  • 9 funds opened new MIRA Pharmaceuticals positions in Q1 2024 and 4 closed out, a net change of +5 holders.
  • The largest MIRA Pharmaceuticals buyer in Q1 2024 was Cross Staff Investments, an estimated $416K added.
  • The largest MIRA Pharmaceuticals seller in Q1 2024 was GTS Securities, an estimated $39.7K sold.

Based on aggregated 13F filings for Q1 2024.